EyePoint Pharmaceuticals is sending its team to New York for investor conferences as it steps up engagement with industry and investment audiences. The outreach follows recent topline Phase 3 LUGANO results for DURAVYU in wet AMD.
published
EyePoint Pharmaceuticals is sending its team to New York for investor conferences as it steps up engagement with industry and investment audiences. The outreach follows recent topline Phase 3 LUGANO results for DURAVYU in wet AMD.
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.